The Psychedelic Report
Why Are We So Easily Deceived About Psychedelics? Featuring Hamilton Morris
October 21, 2024 · 1 hr 10 min
Why listen
Misinformation may be blocking MDMA therapy from millions of PTSD patients, and this episode explains how.
0:00––:––
Enjoy the episode?
Subscribe to The Psychedelic Report
Listen & subscribe on
In this episode
- Why media sensationalism distorted the MDMA clinical trial controversy
- What the FDA's August 9th ruling actually means for psychedelic therapy
- How to evaluate safety and efficacy claims using evidence, not headlines
- What is at stake for patients when public discourse replaces scientific method
About this episode
Is our time quickly becoming the era of “psychedelic McCarthyism”? If we’re not careful, that’s where it looks like we’re heading… In this episode of The Psychedelic Report, Dr. Dave Rabin sits down with Hamilton Morris for an in-depth discussion on the recent controversy surrounding MDMA-assisted therapy and the FDA's pivotal August 9th decision. Together, they address the backlash against MAPS/Lykos and how misinformation has fueled public skepticism and prevented this safe and powerful treatment from getting to millions of patients suffering from PTSD.Hamilton shares his experience from evaluation and investigation of the MDMA clinical trials and sheds light on the media's tendency to sensationalize allegations, including claims of misconduct during the trials. Hamilton and Dr Rabin emphasize the importance of relying on the scientific method, evidence-based data, and research, rather than sensationalized narratives, when assessing the safety and efficacy of MDMA-assisted therapy.
The conversation also explores the broader implications of the FDA's ruling and how the negative hype surrounding psychedelics has overshadowed their significant therapeutic benefits and is causing harm to patients in need. They call for a more balanced and responsible approach to discussing these therapies in both journalism and public discourse, advocating for truth and evidence over fear and speculation.
This episode offers critical insights into the challenges facing psychedelic research today, highlighting the need for thoughtful engagement with the ongoing developments in this field.
- Instagram: https://www.instagram.com/hamiltonmorris/
- Hamilton’s Pharmacopeia: https://www.vicetv.com/en_us/show/hamiltons-pharmacopeia
- The Hamilton Morris Podcast: https://hamiltonmorris.buzzsprout.com/1870388
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
Learn more about your ad choices. Visit megaphone.fm/adchoices
About The Psychedelic Report
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr.
See all episodes →
